Effect of Pravastatin-Induced LDL-Cholesterol Reduction on Coronary Heart Disease and Cerebrovascular Disease in Japanese: Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial (Holicos-PAT)-Reference-Cited by-同舟云学术

Effect of Pravastatin-Induced LDL-Cholesterol Reduction on Coronary Heart Disease and Cerebrovascular Disease in Japanese: Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial (Holicos-PAT)

Published:2002 Issue:5 Volume:9 Page:251-259
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Koizumi Junji¹,Shimizu Masami¹,Miyamoto Susumu²,Origasa Hideki³,Mabuchi Hiroshi¹

Affiliation:

1. School of Medicine, Kanazawa University

2. Himi City Hospital

3. Toyama Medical and Pharmaceutical University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/9/5/9_5_251/_pdf

Reference21 articles.

1. (1) The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chron Dis, 31: 201-306, 1978

2. (2) Stamler J, Wentworth D, Neaton JD, et al.: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous or grded? Findings in 356, 222 primary screeness of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 256: 2823-2828, 1986

3. (3) Pocock SJ, Shaper AG, and Philips AN: Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ, 298: 998-1002, 1989

4. (4) Research Group of the Ministry of Welfare, concerning primary hyperlipidemia of specific diseases: 1986 and 1987 research reports.

5. (5) Shepherd J, Cobbe SM, Ford I, et al.: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med, 333: 1301-1307, 1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects;Expert Opinion on Drug Metabolism & Toxicology;2020-08-11

2. Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan;Pharmacoepidemiology and Drug Safety;2010-02

3. Progression of Non-Culprit Coronary Artery Atherosclerosis After Acute Myocardial Infarction in Comparison with Stable Angina Pectoris;Journal of Atherosclerosis and Thrombosis;2008

4. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: Factors influencing on international application of evidence-based guidelines;International Journal of Cardiology;2007-05

5. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials;Clinical Therapeutics;2007-05